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Cicatricial pemphigoid (CP) is an autoimmune blis-
tering disease that primarily affects mucosal tissues. 
Autoantibodies to laminin-5 have previously been 
detected in certain patients with a CP-like disease; 
however, individuals that exhibit this reactivity pro-
file apparently represent a slnall subset of CP pa-
t ients. In the present investigation, 0 of 18 CP sera 
showed reactivity with laminin-5 by in-.munoblot-
ting. In contrast, 18 of 23 CP sera (78%) recognized a 
180-kDa epidermal antigen that, by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis, co-mi-
grated with BP180, a hemidesmosomal glycoprotein 
associated with two other autoimmune blistering 
diseases, bul~ous pemphigoid and herpes gestationis. 
To investigate further the CP autoimmune response, 
various segments of human BP180 were expressed as 
bacterial fusion proteins and assayed by imnulnoblot-
ting for reactivity with CP patients' sera. The results 
of this investigation delnonstrated that the BP180 
B ullollS pemphigoid (BP) and heq>es ges tationis (HG) belo ng to a group of subep ithel ial blistering diseases associa ted with autoantibodies directed against two hernidesmosornal polypeptides designated 13P1 80 and BP230 [1 - 4). T he 13P230 antigen is restricted to the 
intracellul ar hemidesmosomal plaque [5,6], while BP1 80 is a trans-
membrane glycoprote in with all extracellular domain which har-
bors an il11l11unodominant epitope recognized by both BP and H G 
autoantibodies [7-10] . Rabbit antibodies produced against the 
ectodomain of the murine BP1 80 pro tein have recently been sh own 
to be pathogenically active when passively transferred into neonatal 
BAL13/c mice [11-13] . T he inj ected mice exhibited a blistering skin 
disease that reproduced the key immunopatho logical features ofBP 
and HG: binding of IgG and C3 to the cutaneous basem ent 
membrane zone (13MZ) , ne utrophili c in fi ltration of th e papillary 
dennis, and subepidermal vesiculatio n. 
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goid ; C P, cicatricia l pemphigo id; GST, glutathio ne S-transfcrase; H G , 
hcrpcs gesta ti o n is. 
autoantigen is indeed a major target of CP autoanti-
bodies . Further, two distinct CP-reactive sites were 
identified on the extracellular domain of the BP180 
protein, one located in the non-collagenous (NC) 16A 
domain (at or near the previously defined autoanti-
body-reactive site recognized by bullous pemphigoid 
and herpes gestationis sera) and the other in the 
carboxy-terminal region of this protein. Sixteen of23 
CP sera (70%) reacted with one or both of these 
antigenic sites of BP180. Other immunologic data 
suggested that BP180 may harbor additional CP-
reactive sites. In conclusion, there are now three 
bullous diseases, bullous pemphigoid. herpes gesta-
tionis, and cicatricial pemphigoid, that are known to 
be associated with an autoimmune response against 
the extracellular domain of the BP180 antigen. Key 
1V01,ds: al/toi",,,, II1rity!bl/ 110 liS p elllplr.igoid!lrelll ideslllosollle! 
collage" , J Invest Dennatol 106:141-146, 1996 
C icatricial p emphigoid (CP) comprises a gro up of mucocutane-
o us diseases that, in many respects, I'esembles 13P (for review, see 
p 4]) . I3listers and erosions al'e typica lly observed in mucosal 
m embranes, and the les ions often hea l with scaT form atio n , a 
feature whi ch distinguishes this disease from 13P and H G. A subset 
of pati ents present with localized, inflammato ry, scarring p laques in 
the head <lI1 d neck areas without involvem ent of mucosa l tissues 
[15]. This disease enti ty, known as the Brunsting-Perry syndrom e, 
is classified as a variant of C Po although there is some debate 
concerning this classification [1 4, 16] . 
Peri.lesionul skin and mucosal ti ssue in C P patients show deposi-
tion of imlllunoglobulins (l gG, IgA, and 19M) and C3 at the 
epithelial-stromal junction by direct immunofl uo rescence (.I F) tech-
niques [17-20]. T he immunoreacta.l1ts in BP and HG have been 
loca lized by immulloelectron microscopy to the cytoplasmic 
hcmidesmosolll al plnque of basa l keratinocytes and to the subjacen t 
plasma m embrane region [21-23] , w hereas immune deposits in CP 
have been shown to be ex clusively extl·accllular. with a broad 
distl;bution ex tending from the upper lamin a lucida (immediate ly 
benea th the hemidesmosom e) to the lamiJla densa [24 - 27]. 
T he maj o ri ty of C P patients' sera sh ow 110 circulating autoanti-
bodies when tested by ro utine indirect I I" using cryosections of skin 
o r mu cosa l tissue as substrates . Whe n presen t, CP autoan tibodies 
exhibi t [I" characteristics similar to those of BP sera (i.e., linear 
staining o f the ep ithelia l-stroma l junction), altho ugh CP t ite rs are 
0022- 202X/%/S10.50 ' Copyrigh t © 1996 by The Society for ln vl!stigative Derm atology, Inc. 
141 
142 LlALD ING ET AI-
generall y lower than autoantibody titers in BP [25,2S]. CP autoan-
tibodies a re polyclonal and are predom in antly of the !gG isotype, 
although IgA and Ig M h ave a lso been impli cated in thi s disease 
1.1 7-"lS,20] . Ind irect immunoe lectron mic roscopic studies carri ed 
out w ith CP sera sh owed antibod y binding to sites beneath the 
hemidesmosome and in th e subjacent lamina densa , a patte rn very 
similar to th at of t issu e-bound immunoglobulin s in perilesional skin 
[29-30]. 
N ume ro u s epide rmal antigen s immunoreactive with CP sera 
have b een detected b y immunoblot and immunoprec ipi tation tech-
niques [31-40 1. T h e ident ity of most of these autoan tigens and th e ir 
pathogenic releva n ce is un known . In recent studies, the se ra from 
a sm all number of patients w it h a CP-li ke disease were show n to 
contain autoantibod ies th at labe l th e dermal side of sa lt-split ski n 
and that immunoprecipi tate epiligri n , a protein com p lex containin g 
lamin in-5 (a lso kn own as nicein or kalinin) [3 'J ,39-42] . H owever, 
of th e CP se ra th at contain anti-BMZ autoantibodies, th e maj o ri ty 
labe l th e epiderma l side of sodium chlo ride - split human skin 
[1 4,39] and do not rea ct w ith laminin-5 1.39 1. 
In our expel;e n ce, a hig h percentage of CP sera ex hibit IgG 
reactiv ity aga inst a 180-kDa ep ide rmal antigen that co-migrates o n 
sodium dodecyl su lfate ge ls w ith th e B P1 80 a utoan tigen [32,34J. It 
was fu rthe r sh own by immunop recipitation studies t hat this CP 
antigen h as immunologic c ross- reactivities w ith B P1 80 132,3 8] . 
Nevertheless , th e identity of the l SO- kDa CP anti gen rema in ed in 
q uestio n , partic ularl y in lig h t of the different ultrastru ctural loca l-
ization s obta in ed by immunoreacta n ts in DP and CP (see above). 
The aim of th e present study was to test a group ofCP patients ' sera 
for IgG rea c tivity w ith affinity-p urifi ed bacteria l fusion protein s 
con tai ning region s of the BP1S0 ectodol11ain . Recombinant seg-
m e nts of BP180 th at were tested in cl ude d the previollsly defined 
BP/HG autoantibody-reactive region within the N C16A domain 
and three nested pcptides corresponding to th e ca rboxy-terminal 
regio n of this protein . 
MATEIUALS AND METHODS 
Diagnostic Criter ia of Cicatricial Pemphigoid We illcluded in thi s 
study patiell ts presentin!; with vesicular and/or bu llo us e rup tioll s that led to 
'erosions or the sk ill and 111ucosn l tisslIes. H ea ling and recurren ce of the 
le sions rcsulrcd in scarring . 'T h e skin lesions, w he n presen t, were prinlaril y 
restricted to the head , neck. and upper tru nk. No flexura l involvement was 
seen. Conjunctiva l in vo l vcI11cI1t produced inRalllllHlto ry conjunctivitis and 
sca rring (synechia). In the ora l cavity, the disease prod uced desqu amative 
gingivitis or bu llae and erosio lls of the buccal muCOsa and the soft ;lIld hard 
pa late. In patiellts 'w ith th e L3rullsting-Pc rry varia n t. th e nlU CO liS 111cll1brancs 
were not involved, alld the bullous eru ptions produced sca rrin!; p laques. 
Milia 'were occ~l s i on a ll y detected in these plaques. Histologic cX3111ina t io ll 
of perilcsional areas revea led subepithe lial ves iculation with moderate to 
intense illflammatory infiltratioll ill the upper dermis. Direct IF ana lys is 
showed a lillear deposition of IgG. C3, and, in some cases, IgA along the 
epithelia l-stl'omal junction. III abo ut half of th e cases , low ti te rs of circu-
lating I!;G :lI1ti-LlMZ autoa ntibodies we re detected by indirect IF. When 
tested aga inst normal sa lt-sp li t hUI"'"1 skin. IgG autoa ntibodies from these 
patients consistentl y labeled the ep idermal side of the artificial split. 
Sources of Cicatricial Pemphigoid Sera a nd T issue Samples Sera 
and skin biopsies from 23 representativc C P patients were used in this stud y. 
Th<! re levant clinica l ;lI1 d imllluno logica l data on these pati<!llts arc li sted in 
Table I. Twenty of the 23 C P patients had a chronic and scarring disease 
with a pred ilection for mu cosa l in volvement (espec iall y ora l and ocular) . 
The remaining three C P patients (Cases '17-1 9) had a chronic sca rring 
cutaneous bliste ring disease of the Brunsting-Perry type l '15J. T he patients 
typ ica ll y showed linear deposits of I!;G andlor C3 at the dermal-epidermal 
junction as determined by a direct I F procedure. Li near deposits of IgA at 
the cutancous 13MZ were also seen in '12 of the C P patients; bu t since the 
;lII ti- lgA staining intensity was always weaker than that prod uced by 
:lI1ti- lgG or anti-C3, the d iagnosis of linear I!;A de rma tosis was excl uded. 
Direct immunoclectron microscopy. as pe rformed acco rding to the lI1ethod 
of Prost ef (II [261, de l11 0 ll stratcd thi ck a ll d discon ti nll o ll s inlll'lIt1 C deposits 
loca lized to the lamina densa and the lower part of the 1;lInin a lucida in '1 5 
of 19 CP sallipies and ill two of the three cases with 13runsting-Pcrry 
syndrome. T hese fi ndings >Ire in agreement with previous ly published 
res ul ts 1271. 
Well -cha racte rized sera from Bp (n = 14), I-I G (n = 2). and pemphigus 
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Table I. Clinical Features of Cicatricial Pemphigoid 
Patients 
M lI COcutallcous Les io ns 
Cas<! Sex Age Skin Ocular O ral Nasal Esophagea l Gcnital 
'I F 60 + No + + No No 
2 F 8 1 + No + No No No 
3 F 75 + + + No No No 
4 M 8 1 + No + No No No 
5 M 77 + + + No No 
6 M 63 + No + No No + 
7 F 7(, No No + N o No No 
8 F 78 + No + No No No 
9 F 64 + No + + No No 
III F 59 + No + No No + 
11 F 86 + + + + No No 
12 M 86 + No + No No No 
'13 M 62 + + + No + No 
14 M 68 + + + No No No 
I S F 56 + No + + No No 
16 M 76 + + + No N o No 
17 M 77 + No No No No No 
18 M 52 + No No No No No 
19 M 80 + No No No No No 
20 M 87 -I- No -I- No No + 
21 M 74 -I- -I- + No No + 
22 F 67 + + -I- + No + 
23 F 66 -I- No -I- -I- No No 
foliaceus (PF) patients (n = 5) and fi'o l11 normal volun tee rs (n = 9) werc 
cmployed as controls in th is stud y. A polyclonal rabbit anti se rull1 against 
glu tathione-S- transfera sc (GST) was also included in this panel. 
Generation of purified BP180-GST fusion proteins Four fusion 
proteins containing Sc/tiSI(lscHll fl jnpo l1;c /(1JI GST fused to v:I r"intl s reg ions of 
human 131"180 were produced as described prev iously [10,43 1 using the 
bacre rial expression v<!ctor, pGEX-2T (Pharmacia- LiCB Biotechnology, 
Piscataway, NJ). T he generatioll ofGST-Stl l, containing 42 amino ac ids of 
the 131'1 80 NC1 GA domain (sec F ig 2) has been described in an ea rlier 
report ( 10) . T ltr<!e fu sion proteins, desi!;nated I33, 4710, and 4575. contain 
nested segments of the ca rbox y-terminal region of LlP 180 (sec Fig 2) . The 
eD NA inserts encoding these three ca rboxy- terminal Bp180 segments were 
generated by polymerase chain reaction alllplifi cation 144-45] using the 
cloned 131"180 cD NA (clone 7-Y) as template [8 J. All three amp li fi ca tion 
reactions uti lized the same pos itive strand p" illler: 5'-CGGGATCCGCT-
GACTTTGCTGGAGA TCT-3'. T he nucleotide sequences of the negati ve 
strand primers used to amplify the inserts encoding fusion proteins :133. 
4710. and 4575 are as fo llows: 5'-CGGAATTCACGGCTTGACAG-
CAATAC-3' . 5 ' -CGGAA TTCAAGCAGGGCCCCTGTCACC-3 ' , and 
5' -CGGAATTCAGCTGATGCCGGGTGGCCC-3', resp<!ctivdy. All four 
LlP 180 express ion constructs were subjected to nucieoride seq uence analysis 
[7 ,8J to confi rm the fide li ty of the polymerase chain reaction amp li fication 
and to verify tha t the BP'180 coding rc!;ion was in register with the GST 
readi ng fi·ame. Llacterial extracts con ta in ing the isopropyl-{3-D-thiagalacto-
pyranoside-induced fusion proteins were pr<!pared using N-laurylsa rcosinc 
in T ris-buff"ered sa line containing ethylenediamine tctr"ace tic acid as de-
sc ribed previousl)' [46]. Fnsion proteins wer<! purifl<!d by !;Iutatitione-
a!;a rose affill ity chromatograph y. using 15 mM glu tathione. 2% N-octyl-
glucopyranoside far durion 14 3.46 1. 
Immunoblotting Procedures A tota l prot<!in extr;lct from human 
epidermis, puritied laminin-5, and bacterial expressed GST-B PI 80 fusion 
proteins were assay<!d by immunoblotting for reactivity with CP patient and 
con tro l sera. T hese th ree prote in preparations were fj'actionated by sodium 
dodecyl sul f:lte-po lya Tylal1l ide ge l electrophores is 147.1 and e lectrophoreti-
ca ll y transferred to ni trocellulose membrane l48); however, " distinct 
anti body labe ling procedure was used for each of these test substrates . 
T he imlllunobiotting procedures that were employed in thi s srudy to 
detect reactivity of CP, BI', and contro l sera with BI>180 fus ion proteins 
we re described prev ious ly 12.47-48 1. 13riefly. blots conta ining LlPISO-GST 
fu sion proteins w<! re probed at room temperature with one of the test s<!ra 
diluted I ~O-fo l d in PTX solu tion (0.01 M phosph ate. pH 7.5. 0.2% Triton 
X- l OO. 0. 15 M NaCI. '1111M ethyleneglyco l-bisl {3-aminocthyl etherJ-
N ,N.N ' ,N ' -tetraacetic acid [EGTAJ, 4'1., bovine serum albumin) . The blots 
w<! rc washed 5 X 4 min in GB solution (50 111M tri ethanolamine. pH 7 . ~ , 
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Figure 1. CP sera react by i111111lJnobiotting with a lS0-kDa epider-
mal antigen. Imnlllllobiots containing a human epidermal ex tract wCl'e 
labeled with C P sera nUl1lbers 12, 4. and 14 (lallcs 2 through 4. respectively) . 
As internal standards, blots were hlbcled with well-characterized .131' sera 
dlat reacted either with 13P 180 (lillie I ) or with 131:'230 (/nlle 5). Lalle 6 was 
labeled with a 11 0 1"11) a 1 hU1l1an $cnnn as a negative control. The 111igratio n 
positions of I3P 'I80 and 131'230 arc indicated at the right. All three CP sera 
showed reactivity with a band that co-migrated with I3P1 80. 
0.5% Triton X-l00, 0,1 M NnCI, I 111M EDTA, and 0.1'X. sodium dodecyl 
sulfate) , and the bo und IgG was derected autoradiographicaUy using 
1251_labeled Pro te in A. 
hnmunoblotting aga inst the human epidernwl ex tract was c'"Tied out ;J lso 
as previously reported [4 91- CP and control sera diluted 100-fold in PTX 
solution wcre in cubated with the immobilized protein extracr, and the blots 
were washed as described above. The secondary antibody used in this assay 
was a peroxidase-conjugated goat anti-human IgG (1-1 + L) (lnstitut 
Pasteur , Mantes la o qucttc, France) . 
Blots containing laminin-S (I p.g/lane, purified according to the protocol 
of Verrando e, al [SO]) were incubated overnight at 4°C with a C I:' se rulll 
diluted 1:2 ill buffer A (10 mM Trig, pl-l 7.4. 0.15 M NaCI. 1 mM EDTA. 
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3% bovine serum albumin, and 0.1 % Tween-20), T he blots were washed in 
buffer A and then incubated with a biotinylated goat anti-human IgG 
antibody (diluted at 1:500 in bulfer A). Detection of antibody binding was 
accomplished using avidin-conjugated horseradish peroxidase fo llowed by 
addition of di:l11linobenzidine and H 2 0 2 • 
RESULTS 
BP and CP Sera Exhibit Sitnilar Reactivity Patterns by 
ImlUunoblot Analysis Twenty-three CP pa tienes' ser'a w e re 
assayed by iml11unoblotting for reactivity with a human epide rmal 
extract (Fig 1, Table II). Identical results were obtained using a 
tota l protein extract from cultured buman keratinocytes. WeU-
chara cte r;zed BP scra that react with BP230 (n = 4) or BPI80 (n = 
4) w ere used as standard controls in tlus analysis . Eighteen oftbe 23 
CP sera (78%) specifi caUy reacted with a i80-kDa antigen, that 
co-migrated with BP1S0, while three of these also recognized a 
band that co-migrated with BP230. One CP serul11 reacted exclu-
sively with a 230-kDa antigcn, and anothe r reac ted only with a 
band of 240 kDa, which mig rate d slightly slower than BP230. 
Three CP sera failed to react with th e 180- or 230/240-kDa 
antigens (Table II). Normal human sera sh owed no specific 
labe ling in this assay. 
CP Sera Show no Reactivity with Purified Latninin-5 Eig h-
teen CP patients (Patients 1-18) listed in Table I were tested for 
reactivity with purified I.millin-S. None of the eighteen CP sera 
showed detectable reac tivity by this iml11unoblot technique. Poly-
clonal antise ra raised against each of the three chajlls of laminin-S 
(nice in / kalinin), a3, {33, and y2, were pre pared in the laboratory of 
Jean-Paul Ortonne (Nice, France) and were used as positive 
controls for these il11l11unoblotting experiments. 
CP Sera React with Two Distinct Sites on the BP180 
Ectodomain To charac terize furthe r CP patient autoantibody 
reactivity, w e assayed the reactivity of 23 CP patients ' sera with 
BP180-GST nrsion proteins using an immunoblot protocol. One 
fusion protein , S~l , contains a 42 am ino acid stretch of the BP180 
ectodomain located ncar the m embrane- spa1111ing region. The 
other three nlsion prote ins contain nested segments of the carbox),-
Table II. Epitope Mapping Studies of Cicatricial Petnphigoid Autoantibodies" 
Imll1unoblotting 
Direct B 1'1 80 Fusion Proteins 
Iml11unoelectron Epidermal 
Case Direct IF Indirect IF Microscopy Extracts S~l 133 4710 4575 
C3 1:20 ( - ) (- ) ++ ++ + ++ 
2 IgG, C3 (- ) LL, LD BP1 80 +++ + +/- + 
3 IgG . IgA. C3 ( - ) LL, LD 81>230 (- ) ( - ) ( - ) (- ) 
4 IgG, IgA. C3 1 :1 00 LL. LD 131>1 80 ( - ) ++ + +++ 
5 19G. 19A . C3 1: '10 LL. LD 81'230, 81'180 ( - ) ( - ) (-) ( - ) 
6 IgG , C3 (- ) NO BP1 80 ( - ) ( - ) ( - ) ( - ) 
7 19G, 19A, C3 (- ) LL, LD (- ) + + +/- + 
8 C3 1 :40 LL. LD 81'1 80 +++ + +1- + 
9 IgG. IgA. C3 (-) LL. LD 131'1 80 ++ (-) (- ) ( - ) 
10 IgG , C3 ( - ) LL I3P230 , 131'1 80 ++ (- ) (- ) ( - ) 
11 19G. 19A. C3 (- ) LL, LD 131'180 (- ) ( - ) (- ) ( - ) 
12 IgG. IgA, C3 1 :40 LL, LD BP180 ( - ) ( - ) (- ) ( - ) 
13 IgG, IgA . C3 ( - ) LD .81'180 ( - ) +++ +1- + 
14 IgG, C3 1: 10 LL. LD 131'1 80 + ++ + + 
15 IgC, C3 1;20 LL, U ) BI:'180 +++ ++ ++ +1-
16 19G. IgA. C3 ( - ) LL, LD 131:'180 (- ) + +1- + 
17 IgG, C3 1:10 LL, LD BP230. 131:'1 80 ( - ) + ++ ++ 
18 19G, lgA, 3 1:10 LL, LD 131'230 ( - ) ( - ) (- ) ( - ) 
19 IgC, C3 ( - ) ( - ) 13P1 80 ++ + +1- + 
20 C3 ( - ) LL. LD 8P1 80 + + + + 
21 IgG (- ) ( - ) ( - ) (- ) ( - ) ( - ) ( - ) 
22 IgG. IgA, C3 t:IOO LL, LD 81'180 ++++ ++++ + + ++ ++++ 
23 IgG. IgA, C3 1 :10U LL, LD 81:'1 80 ++++ + + +1-
" LL. l a mil1 ~l lucid;,; tD. lamil1;\ dellsa. In t.ensity of inullllll obiot reacrivity was quantir:,tivl'iy rared 011 a 4 + scale. where (- ) = 110 detectable reactivity and ++++ = hi gh est 
level of rCi"ICfivity o b .. c rvcd. 
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Figurc 2. Sch cmatic diagram ofthc BP180 antigcn and BP180-GST 
fusion protcins. A schematic of 13P180 is shown with the BP I SO- CST 
fusion proteins aligned correspondingly. D(TM). the putative membranc-
spanning domain; 0 , the position ofth" previous ly reported 'Illtigenic region 
recognjzed by 131' and HC sera (10); 0, the ex tracellular coU<lgeno ll s 
domains. Sill is a CST fu sion prote in that encodes a 42- amino acid stretch 
of 13P] 80 beginning 18 amino acids outside of the membrane-spanning 
domain '1I1d including the BP/ I-IC epi tope. CST fu sion prote ins 133, 4710, 
and 4575 represent a nested set of 131'180 C-terminal truncations with 
lengths of 133 , 94 . and 49 am ino acids, respectively. 
termin al regio n of BP1S0. Figure 2 shows a schem atic diag ram 
depictin g the re lative sizes and positions of th e clon ed segm ents of 
BP180. R ecombin an t GST was used as a negative control in this 
immu noblot study. 
Overall , t 6 of 23 CP sera (70'10) reacted w ith at least one of the 
BP180 fusion proteins. T h e sixteen immunoreactive CP patien t's 
sera fell into th ree groups ba sed on reactivity pa tte rn s: (i) two sera 
reacted exclusively w ith St. l ; (ii) four sera reacted exclusively w ith 
fusion prote ins encoding carboxy-terminal regions of BP1SO; (iii) 
10 sera reacted w ith botb St.1 and ca rboxy-termin al BP180 fu sion 
protei n.s. Represen tative im mullobiots a rc shown in Fig 3 , and the 
results of all 23 sera are shown in Table II. None of the control sera 
'(n iJ1e norma l human se ra and five pemphig us fo liaceus sera) 
sh owed reactivity with any of the BPISO fu sio n proteins included in 
this stu dy. In additi o n , 14 BP sera and 2 HG sera were tested for 
reactivi ty w ith these fusion proteins. Five BI) sera and both of the 
HG sera reacted strongly and excl usive ly w ith St.l. Six BP se ra 
reacted stro ngly w ith St. l an d o nl y weakly w ith the ca rboxy-
terminal fusion proteins. T hree BP sera fa iled to react w ith an y of 
the BP180 fusio n prote ins tested . 
F igurc 3. CP sera react by immUllO-
blotting with recombinant forms of 
human BP180. ImlTIulloblots were run 
using the four CST -BP 180 fu sion pro-
te ins depicted in Fig 2. In all three 
panels. (niles 1 th[ough .'i were loaded 
with fusio n proteiJ1S Sil l . 4575. 4710, 
133, and recombinant CST, respectively. 
- . the migration positions of the llP180 
fusion proleins (from top to bottom: 133, 
4710, 4575 , and Sil l ); <l, the migration 
position of CST. T he ilTll11unoblots were 
labeled with C P sera as indicated at the 
top of each panel. Each of these three C P 
sera exhi bits a different pattern or immu-
noreactivity and is rep resentative of the 
reactivity patte rns shown by other CP 
sera as presented in T"ble II . CP-22 
shows reactivity with all tour 51'180 fu-
sion proteins. CP-17 reacts only with the 
tl,rcc C-tenninal fusion proteins. C P-9 
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D ISCUSSION 
T his study firml y establi shes tha t the BPIS0 epidermal antigen is a 
major antigenic ta rget of IgG autoan tibodies produced by CI' 
patients. Mo reover , we have shown that CP au toantibodies are 
directed aga in st at least two distinc t antigenic sites of the extracel-
lular doma in of BP180. O n e CP-reactive site is a 42- al11ino acid 
stretch with.in the non-collagenous NC16A dom ain, and the other 
site is loca ted n ear th e BP1S0 carbo}.J'-te rminus . Seven ty percent of 
th e CP sera reacted w ith o ne o r both of these two antigell ic regions 
of th e extra ce llul a r domain of BP1S0. Fo u r of th e C P sera that 
fai led to recognize e ithe r of these two BP180 sites did react with a 
l S0-kDa epidermal antigen b y immu no bl ot, suggestin g (as dis-
cussed be low) that additional BP180 antigeni c sites m ay be targeted 
by certain CP autoantibo dies. 
In thi s study, well-ch aracterized C P sera w ere tested by il11l11u-
no blottin g for reactiv ity with human epide rmal antigens and wi th 
recombinan t form s of human B P1 80. T hese two immunological 
assays yielded con cordant resul ts in the great maj o rity of the cases 
studi ed (i .e., 14 C P sera showed reac tivity w ith a l SO- kDa band 
from human epidermis an d also reacted with at least o ne of the 
recombinan t forms ofBP180, w hil e anothe r three C P sera fa iled to 
react with the epide rmal o r recombin ant form s ofBPlS0). Two CP 
sera (Cases 1 and 7) reacted w ith recombin an t BP1 80 but showed 
no reactiv ity w ith a l 80- kDa antigen trom the hum an epidermal 
extract . T hi s res ult m ay w ell indicate th at the recombillant BP180 
immunoassay is m ore sen sitive th an immun o blotting against an 
epidermal extract. Such a phenom enon was previously reported in 
an epitope m apping study with BP and HG sera [1 0). Four other CP 
sera included in the presen t investigation (Cases 5, 6, 1.1, and 12) 
reacted with a 180- kDa band f)'om human epide rmis but fail ed to 
react w ith the fo ur BP1S0 fu sio n proteins. A likely explana tion for 
these last resul ts is that cer tain CP sera recognize BP180 epitopes 
not present on any of th e recomb inan t forms of BP1 80 used in this 
study. H owever , on e cannot formally r ul e out th e possibility that a 
180-kDa epiderm al anti gen distinc t from BP180 is recognized by 
certain C P sera. 
T he BPI S0 epide rmal antigen was o ri ginally identif ied based 011 
its reactivity with BP autoantibodies (2). More recently. our labora-
tory has defin ed an immunodomin an t an tigenic site (M CW-1) 
w ithill th e extracellular N C 16A domain of thi s protein w hich is 
recognized b y the m ajority of bo th BP and HG sera [10). Autoan-
tibody reactivi ty against the M C W-1 site too k o n added signifi-
ca nce with the recent demonstra tion tha t an tibodies ge ne rated 
against th e corresponding segm en t of murine 6P1 80 were capable 
of inducin g a subepid ermal bli stering disease in BALBI c mi ce using 
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a passive transfer protocol rI1] . Based o n the results of the present 
study, CP becom es the third disease associated with an autoimmune 
response against the BP180 N C16A domain. All three diseases. BP, 
HG, and cr, are characterized by the presence of subepithelial 
vesicles associated with an inflammatory response. Further dissec-
tion of the complex hum o ral autoimmune response in these patients 
may help to explain the heterogeneous nature of the clinical and 
immunopathological features o bserved in this gro up of diseases. 
An interesting correlation is beginnin g to em erge re lating the 
molecular mapping of autoantibody-reactive sites on BP180 and the 
ultrastru ctural mapping of autoantibody staining patterns in peri-
lesional tissue of bullo us patients. BP180-positive BP se ra show 
specifi c labeling of the epidermal hemidesmosom e at the level of 
the basal keratinocyte plasma membrane and the upper lamina 
lucida immediate ly subja cent to the keratinocyte [21- 23,51 ]. I.n 
accordance with this localization pattern, a maj or antigenic deter-
minant recognized b y BP au toantibodies (MCW-l) has been 
mapped to a site on the BP180 ectodomain located just 18 amino 
acids from the m cm bnJ!le-spanning domain [1. 0]. Tn contrast to the 
upper lamina lucida-restricted local ization profil.e of BP autoanti-
bodies, tissue-bound IgG autoantibodies £i'om CP patients generaUy 
show a broader basa l lamina labelin g pattel'll which typicaUy 
exten ds into the lamina densa [24-27]. Consistent with this loca l-
ization profile is the identification of more than one CP autoanti-
body-reactive site 011 the BI>180 ectodo main described in this 
report. As reported in Table II, 10 C P sera showed reactivity b y 
immunoblot with both the MCW-l-containing segment and the 
C-terminal region of EP180. 
T he newly identified reactivity of CP IgG with the C-terminal 
region of BP180 may account for the C P IgG reactivity with the 
lower lamina lucida and lamina densa detected by direct iml1luno-
electron microscopy. Of the 14 C P patie nts that were shown b y 
immunoblotting to contain circulatin g I. gG directed against the 
BPI80 C -terminal fusion prote in s, 12 ex hibited IgG staining of the 
lamina densa and the remaining two showed no detectabl e staining 
of the BMZ. Of particular note, CP Patient 13 showed IgG 
deposition excl usively at the lamina densa, and the corresponding 
seru m recognized the BP'\ 80 C -terminal segm ent but not the 
membrane proximal region. Also of interest is CP Case 10, in which 
tissue bound IgG was restricted to the uppe r regions of th e lamina 
lucida, and the corresponding serum reacted only with the m em-
brane-proximal region (Sil '\) and not w ith the C -terminal region of 
BPlS0. Six of 14 BP sera also reacted with the C - term inal region of 
BP180 , but in eac h of these cases this reactivity was much weaker 
than that directed against the regio n represented by the Sill fusion 
protein. Taken together, the above data suggest that the BPIS0 
ectodomain exists in an extended conformation that traverses the 
lamina lucida , such that the ca rboxy-te rminus closely approaches, 
or possibly projects into. the lamina densa . Direct support for such 
a protein confo rmatio n has very recently been obtained by ultra-
structural localization of rabbi t antibodies prepared against various 
segm ents of the BP180 ectodomain (Bedane C el aI, manuscript ill 
preparation). This informati on has impl.ication s in terms of potential 
protein-protein interactions invo lving thc BP180 proteLn. 
The findings from this and other studies firmly esta blish that 
BP180 is a maj or target of BP, HG, and CP autoantibodies 
[32,34,38] . Disease-specifi c differences in the ~ine specificities of 
anti-BP1 80 autoantibodies may help to exp lain observed differences 
in certa in clinical and immunopatho logica l features of these dis-
eases. For exa mple, the reactivity of CP autoantibod ies with the 
BP180 C-terl11inal domain m.1Y account for the basal lamina 
disruption o bserved in CP and the chanl cteristic scarring associated 
with this disease. T he new ly identified CP autoantibody-reactive 
sites o n the BP18U ectodom;1in are predicted to be accessible to 
circulatin g antibodies prior to tissue injury and, thus, m ay be 
involved in the initial stages of lesion formation in CPo Future 
studies will add ress the pathogenic relevance of antibodies directed 
against the BPJ 80 ca rboxy-terminal region usin g the passive trans-
fer mouse system . 
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